Literature DB >> 12730724

Familial hypercholesterolemia in Morocco: first report of mutations in the LDL receptor gene.

Mariame El Messal1, Karima Aït Chihab, Rachid Chater, Joan Carles Vallvé, Faïza Bennis, Aïcha Hafidi, Josep Ribalta, Mathilde Varret, Mohammed Loutfi, Jean Pierre Rabès, Anass Kettani, Catherine Boileau, Luis Masana, Ahmed Adlouni.   

Abstract

Familial hypercholesterolemia (FH) is a genetic disorder mainly caused by defects in the low-density lipoprotein receptor (LDLR) gene, although it can also be due to alterations in the gene encoding apolipoprotein B (familial defective apoB or FDB) or in other unidentified genes. In Morocco, the molecular basis of FH is unknown. To obtain information on this issue, 27 patients with FH from eight unrelated families were analyzed by screening the LDLR (PCR-SSCP and Southern blot) and apoB genes (PCR and restriction enzyme digestion analysis). None of the patients carried either the R3500Q or the R3531C mutation in the apoB gene. By contrast, seven mutations in the LDLR gene were identified, including five missense mutations on exons 4, 6, 8, and 14 (C113R, G266C, A370T, P664L, C690S) and two large deletions (FH Morocco-1 and FH Morocco-2). The two major rearrangements and the missense mutation G266C are novel mutations and could well be causative of FH in the Moroccan population. This study has yielded preliminary information on the mutation spectrum of the LDLR gene among patients with FH in Morocco.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12730724     DOI: 10.1007/s10038-003-0010-x

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  25 in total

1.  The molecular basis of familial hypercholesterolemia in The Netherlands.

Authors:  S W Fouchier; J C Defesche; M W Umans-Eckenhausen; J P Kastelein
Journal:  Hum Genet       Date:  2001-11-09       Impact factor: 4.132

2.  Molecular genetics of familial hypercholesterolaemia in Norway.

Authors:  T P Leren; S Tonstad; K E Gundersen; K S Bakken; O K Rødningen; H Sundvold; L Ose; K Berg
Journal:  J Intern Med       Date:  1997-03       Impact factor: 8.989

3.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.

Authors:  W T Friedewald; R I Levy; D S Fredrickson
Journal:  Clin Chem       Date:  1972-06       Impact factor: 8.327

4.  Identification of recurrent and novel mutations in the LDL receptor gene in German patients with familial hypercholesterolemia.

Authors:  M S Nauck; W Köster; K Dörfer; J Eckes; H Scharnagl; H Gierens; H Nissen; M A Nauck; H Wieland; W März
Journal:  Hum Mutat       Date:  2001-08       Impact factor: 4.878

5.  Evidence for a third genetic locus causing familial hypercholesterolemia. A non-LDLR, non-APOB kindred.

Authors:  L Haddad; I N Day; S Hunt; R R Williams; S E Humphries; P N Hopkins
Journal:  J Lipid Res       Date:  1999-06       Impact factor: 5.922

6.  Mutations in the apolipoprotein (apo) B-100 receptor-binding region: detection of apo B-100 (Arg3500-->Trp) associated with two new haplotypes and evidence that apo B-100 (Glu3405-->Gln) diminishes receptor-mediated uptake of LDL.

Authors:  E Fisher; H Scharnagl; M M Hoffmann; K Kusterer; D Wittmann; H Wieland; W Gross; W März
Journal:  Clin Chem       Date:  1999-07       Impact factor: 8.327

Review 7.  Single-strand conformation polymorphism analysis with high throughput modifications, and its use in mutation detection in familial hypercholesterolemia. International Federation of Clinical Chemistry Scientific Division: Committee on Molecular Biology Techniques.

Authors:  S E Humphries; V Gudnason; R Whittall; I N Day
Journal:  Clin Chem       Date:  1997-03       Impact factor: 8.327

8.  Genetic localization to chromosome 1p32 of the third locus for familial hypercholesterolemia in a Utah kindred.

Authors:  S C Hunt; P N Hopkins; K Bulka; M T McDermott; T L Thorne; B B Wardell; B R Bowen; D G Ballinger; M H Skolnick; M E Samuels
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-04       Impact factor: 8.311

9.  The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA.

Authors:  T Yamamoto; C G Davis; M S Brown; W J Schneider; M L Casey; J L Goldstein; D W Russell
Journal:  Cell       Date:  1984-11       Impact factor: 41.582

Review 10.  Molecular genetics of the LDL receptor gene in familial hypercholesterolemia.

Authors:  H H Hobbs; M S Brown; J L Goldstein
Journal:  Hum Mutat       Date:  1992       Impact factor: 4.878

View more
  6 in total

1.  Autosomal recessive hypercholesterolaemia in a Morrocan family due to a mutation of the G266C LDL receptor.

Authors:  Siham El Aziz; Asma Chadli; Hassan El Ghomari; Ahmed Farouqi
Journal:  BMJ Case Rep       Date:  2012-05-23

2.  Familial hypercholesterolemia associated with severe hypoalphalipoproteinemia in a Moroccan family.

Authors:  Karima Ait Chihab; Rachif Chater; Ana Cenarro; Anass Kettani; Sergio Castillo; Mohamed Loutfi; Josep Ribalta; Ahmed Adlouni; Miguel Pocovi; Mariame El Messal
Journal:  J Genet       Date:  2007-08       Impact factor: 1.166

Review 3.  ApoB-100 R3500Q mutation in the Lebanese population: prevalence and historical review of the literature.

Authors:  Amira S Sabbagh; Rose T Daher; Zaher K Otrock; Rabab N Abdel Khalek; Ghazi S Zaatari; Rami A R Mahfouz
Journal:  Mol Biol Rep       Date:  2006-12-08       Impact factor: 2.316

4.  Common and rare single nucleotide polymorphisms in the LDLR gene are present in a black South African population and associate with low-density lipoprotein cholesterol levels.

Authors:  Tertia van Zyl; Johann C Jerling; Karin R Conradie; Edith J M Feskens
Journal:  J Hum Genet       Date:  2013-11-28       Impact factor: 3.172

5.  Molecular Characterization of Familial Hypercholesterolemia in a North American Cohort.

Authors:  Abhimanyu Garg; Sergio Fazio; P Barton Duell; Alexis Baass; Chandrasekhar Udata; Tenshang Joh; Tom Riel; Marina Sirota; Danielle Dettling; Hong Liang; Pamela D Garzone; Barry Gumbiner; Hong Wan
Journal:  J Endocr Soc       Date:  2019-11-29

6.  Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes.

Authors:  Athar Khalil; Batoul Dekmak; Fouad Boulos; Jake Kantrowitz; Avrum Spira; Junya Fujimoto; Humam Kadara; Nehme El-Hachem; Georges Nemer
Journal:  Front Oncol       Date:  2018-10-30       Impact factor: 6.244

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.